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temporal lobe epilepsy with mesial temporal 
sclerosis: hippocampal neuronal loss as a 
predictor of surgical outcome
Epilepsia do lobo temporal com esclerose mesial temporal: o padrão da perda neuronal 
hipocampal como preditor do prognóstico cirúrgico
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Penteado Lancellotti²,³, Murilo Martinez Marinho¹, Ricardo Silva Centeno¹, Esper Abrão Cavalheiro4, Carla 
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Mesial temporal sclerosis (MTS) is the most common 
pathological finding in drug refractory, chronic temporal 
lobe epilepsy (TLE)1. Mesial temporal lobe structures with 
a sclerotic hippocampus have been considered the site of 
seizure onset for most TLE patients, and hippocampal 
sclerosis (HS) has been considered essential for MTS diag-
nosis. Surgery has become the treatment of choice in the 
management of patients with this epilepsy syndrome2,3. 
Tailored resections of temporal neocortex and mesial tem-
poral structures, including hippocampus and amygdala, are 
an established epilepsy treatment modality and offer a fa-
vorable outcome in approximately two-thirds of patients4,5.
The reason why around one-third of individuals with this 
epilepsy syndrome still present seizures after surgical treatment 
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ABStrAct
Objective: To analyze retrospectively a series of patients with temporal lobe epilepsy (TLE) and mesial temporal sclerosis (MTS), and the 
association of patterns of hippocampal sclerosis with clinical data and surgical prognosis. Method: Sixty-six patients with medically refrac-
tory TLE with unilateral MTS after anterior temporal lobectomy were included. Quantitative neuropathological evaluation was performed on 
NeuN-stained hippocampal sections. Patient’s clinical data and surgical outcome were reviewed. Results: Occurrence of initial precipitating 
insult (IPI), as well as better postoperative seizure control (i.e. Engel class 1), were associated with classical and severe patterns of hippocam-
pal sclerosis (MTS type 1a and 1b, respectively). Conclusion: Quantitative evaluation of hippocampal neuronal loss patterns predicts surgical 
outcome in patients with TLE-MTS.
Key words: epilepsy, temporal lobe, mesial temporal sclerosis, hippocampal sclerosis, pathology, surgical prognosis.
reSUMO
Objetivo: Analisar retrospectivamente uma série de pacientes com epilepsia do lobo temporal (ELT) e esclerose mesial temporal (EMT), bem 
como correlacionar os padrões de esclerose hipocampal com os dados clínicos e o prognóstico cirúrgico. Métodos: Foram incluídos neste 
estudo 66 pacientes com ELT refratária a tratamento medicamentoso e com EMT unilateral submetidos à lobectomia temporal anterior. A 
análise neuropatológica quantitativa foi realizada em seções hipocampais imunomarcadas com NeuN. Dados clínicos e resultados do acom-
panhamento pós-cirúrgico foram revisados. Resultados: Ocorrência de evento precipitante inicial e melhor controle de crises após a cirurgia 
(i.e. classe 1 de Engel) foram associados aos padrões clássico (EMT tipo 1a) e severo (EMT tipo 1b) de esclerose hipocampal. Conclusão: A 
análise quantitativa do padrão de perda neuronal do hipocampo é capaz de predizer o prognóstico cirúrgico em pacientes com ELT-EMT.
Palavras-Chave: epilepsia do lobo temporal, esclerose mesial temporal, esclerose hipocampal, patologia, prognóstico cirúrgico.
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has been a matter of debate6. Among other factors, it has been 
suggested that different patterns of neuronal cell loss within 
hippocampal subfields may be implicated in surgical results6,7.
The aim of this study was to analyze retrospectively a series 
of 66 patients with TLE and MTS, as well as investigate the asso-
ciation of clinical data, patterns of HS and surgical prognosis.
MetHODS
Subjects
Sixty-six consecutive patients, 33 men (50.0%), mean age 
37±11.41 years, with medically refractory TLE with unilater-
al MTS on MRI, 36 (54.5%) with right- and 30 (45.5%) with 
left-hippocampal resections, were included in this study. 
Diagnosis was established according to previously reported 
clinical and electrographic characteristics2. Patients who did 
not achieve seizure control despite of adequate use of at least 
two first-line antiepileptic drugs (AEDs), in mono or poly-
therapy, and up to toxic levels, were qualified as medically 
refractory. The study was approved by the Ethics Committee 
of our institution (CEP 2009/10) and informed consent was 
given from all patients.
Clinical features were retrospectively recorded accord-
ing to a specific protocol developed for this study. Presence 
and age of  initial precipitant insult (IPI) defined by Mathern 
et al.8, age at onset of habitual seizures, defined as the age 
at which habitual and recurrent seizures developed, as well 
as duration of epilepsy, were registered. The duration of epi-
lepsy was defined as the interval between the age at onset of 
habitual seizures and the time of surgery. Average frequency 
of preoperative complex partial seizure per month and the 
mean number of generalized tonic-clonic seizures (GTCS) 
throughout lives, classified in > or <20, were also registered.
All patients had extensive presurgical evaluation includ-
ing high-resolution 1.5T MRI (Siemens Somaton or Phillips 
Gyroscan equipment), prolonged non-invasive video-EEG re-
cording and neuropsychological testing. All patients had clear 
MRI findings consistent with unilateral MTS, defined as variable 
degrees of HS (atrophy, increased T2 and decreased T1-weighted 
signal, and disrupted internal structure of the hippocampus), at-
rophy and signal alteration of amygdala and temporal pole on 
visual inspection of MRI pictures. Patients with unilateral MTS 
associated with additional abnormalities besides brain atrophy 
detected by visual inspection were excluded.
Prolonged non-invasive video-EEG monitoring was per-
formed on a 32-channel digital equipment (Biologic® and 
Ceegraph® software). Electrodes were placed according to the 
10–20 International System, plus intermediary temporal and 
sphenoidal electrodes. In order to record ictal events, AEDs were 
tapered off or completely withdrew at physician’s discretion. The 
frequency and location of interictal epileptiform discharges were 
visually assessed on 5-minute EEG samples per hour, 24 hours 
per day, and ictal EEG recordings were also analyzed.
When concordant data was obtained in this evaluation, 
including neuropsychological assessment, a surgical resec-
tion was performed. Surgical procedure consisted on a re-
section of 3.5 cm of temporal neocortex from temporal pole 
on dominant hemisphere (4.5 cm from the non-dominant) 
associated with a 3.5 cm resection of hippocampus and 
two-thirds of amygdala. All patients were followed-up for at 
least six months after surgery, and seizure control was de-
fined according to Engel classification4.
tissue preparation
The hippocampi of all patients were collected from the pe-
riod of 2005 to 2011 from the archives of neuropathology, and 
those with less than three subfields or without CA1 and/or 
CA4 sectors represented in the tissue were excluded.
Five-mm-thick slices along the hippocampus anteropos-
terior axis were dissected, fixed overnight in 4% formalin and 
processed into liquid paraffin. A single block corresponding 
to the mid hippocampal body was selected from each case 
for histopathological examination9 and cut at 7 µm (Leica, 
Germany), expanded in hot water, mounted on slides coat-
ed with silane and air-dried at 56°C overnight in an incuba-
tor. Two slides of each case were deparaffined in xylol and 
descending alcohol concentration. One was stained with 
hematoxylin and eosin (HE) for pathological diagnosis, and 
the other was submitted to an automated staining appara-
tus (Autostainer Link 48, Dako, USA) for NeuN immuno-
histochemistry (Chemicon, Temecula, USA, dilution 1:1000, 
pretreated in PT Link equipment, Dako, USA) and counter-
staining with hematoxylin. All tissue specimens were qual-
itative and quantitative analyzed by two independently ob-
serves (AJ and RN) both in NeuN and HE stained slides.
Thirteen hippocampi specimens obtained from autopsy of 
neurologically healthy subjects without a history of epilepsy 
served as controls (mean age 57.6±14.34 years). HE and NeuN 
staining method were carried out on the postmortem tissue. 
There was no difference accuracy between control’s HE- and 
NeuN-stained sections as reported in previous studies6,7.
Neuronal cell counts
All epilepsy tissue and controls specimens were analyzed 
according to Blümcke et al.7. Microscopically images were 
obtained utilizing an E600 microscope equipped to Moticam 
2300 camera (Nikon, Japan). Measurements of neuronal cells 
were performed on ImageJ software (National Institutes of 
Health, NIH, USA). Immunohistochemically stained neu-
ronal cell bodies were visualized on the computer screen 
(Motic images plus software). Hippocampal subfields were 
identified using 2x objective lens, and four randomly regions 
in each sector (CA1 – CA4), representing 0.0625 mm², were 
outlined. Within these visual fields, all NeuN-positive neu-
rons, despite size and morphology differences, were counted 
at objective 20x. For each subfield, neuronal cell density was 
calculated (neurons x 10-4/µm²).
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Statistical analysis
Values of neuronal cell counts from each hippocam-
pal subfield were transformed into Z-scores. Z-score is the 
number of standard deviation from the mean expected val-
ue, which in this case is the mean controls subfields density 
values, and is calculated according to Z = (score - mean of 
the control)/standard deviation of the control population. 
Results that are more than two standard deviation away 
from the mean expected value were considered abnormal; 
only negative Z-scores were relevant. The different patterns 
of HS were determined according to6: no MTS, Z-score <2 in 
all hippocampal subfields; MTS type 1a, Z-score <2 in CA2, 
but >2 in remain sectors; MTS type 1b, Z-score >2 in each 
subfield; MTS type 2, Z-score >2 in CA1 and <2 in CA4; MTS 
type 3, Z-score >2 only in CA4.
To analyze the importance of clinical data on the different 
patterns of HS, variance analysis with one-way ANOVA was 
chosen. Statistical evaluation was carried out in SPSS 10.0 for 
Windows, version 10.01, and p values <0.050 were considered 
as statistical significant.
reSUltS
In our series of 66 patients, four distinct patterns of HS 
were recognized as suggested in a previous study7: no MTS 
(n=3, 4.5%, Fig 1A), MTS type 2 (n=4, 6.1%, Fig 1B), MTS 
type 1a (n=18, 27.3%, Fig 1C) and MTS type 1b (n=41, 62.1%, 
Fig 1D). Atypical end folium sclerosis (MTS type 3) was not 
found in this cohort of surgical specimens.
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Fig 2. Distinct patterns of hippocampal sclerosis could be 
identified in this series from the analysis of z-scores: no MTS, 
neuronal cell loss within the first standard deviation compared 
to controls (Z-score <2 in each subfield); MTS type 1a, significant 
cell loss detected in CA1 and CA4 (Z-score >2) with preservation 
of neurons in remain sectors (Z-score <2); MTS type 1b, severe 
hippocampal sclerosis in all subfields (Z-score >2 in CA1-CA4); 
MTS type 2, significant loss of neurons restricted to CA1-sector 
and only mild pathology within the other hippocampal subfields 
(Z-score <2 in CA2, CA3 and CA4). Z-CA1-CA4, Z-score of CA1-CA4; 
open circles, patients which scape from the determining patterns. 
MTS: mesial temporal sclerosis.
Neuropathological analysis
In any MTS group, hippocampal subfields neuronal cell 
densities were similar as compared to autopsy control values 
(within first fold standard deviation, Fig 2).
In MTS type 1a, the CA1 and CA4 subfields were the most 
affected (mean neuronal densities ranging from 20.6%±7.8% in 
CA1 and 27.5%±13.7% in CA4 compared to controls, Table 1) 
while in MTS type 1b a severe neuronal loss in all hippocam-
pal subfields with a mean loss of 70 to 80% was observed 
(neuronal densities in CA1 = 0.54±0.249 x10-4 neurons/µm², 
CA2 = 0.98±0.602 x10-4 neurons/µm², CA3 = 0.76±0.413 x10-4 
neurons/µm², CA4 = 0.51±0.346 x10-4 neurons/µm²) (Table 1).
MTS type 2, an atypical pattern of severe neuronal loss 
almost restricted to subfield CA1, presented a mean cell den-
sity of 15.0%±5.3% compared to control values (Table 1), but 
only a mild decrease in CA2, CA3 and CA4 ( first to second 
standard deviation, Fig 2).
clinipathological association
Gender, side of resection, age at surgery and mean age 
at epilepsy onset were closely similar among patients with 
distinct patterns of HS. Monthly seizure frequency and esti-
mated lifetime GTCS did not show influence on severity of 
hippocampal cell loss (data not shown). Although not statis-
tically significant, there were differences in mean duration of 
epilepsy between the MTS patterns (Table 2), with shortest 
duration of epilepsy to surgery for no MTS patients.
Fig 1. Patterns of hippocampal sclerosis (all NeuN-stained 
sections). (A) No MTS. No loss of neurons detected in 
all subfields (CA1-CA4). (B) MTS type 2 (CA1-sclerosis). 
Predominant neuronal loss in CA1 subfield. (C) MTS type 1a 
(classic hippocampal sclerosis). Significant neuronal loss 
from CA1 and CA4 with better preservation of neurons in CA2. 
(D) MTS type 1b (severe hippocampal sclerosis). Total HS with 
neuronal loss in all subfields and in the dentate gyrus. Scale 
bars 1mm. *For regions with significant cell loss. 
MTS: mesial temporal sclerosis; HS: hippocampal sclerosis.
A
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outcomes were observed for the MTS type 1a and MTS type 1b 
cases, with seizure relief ranging from 75.6 to 83.3%. Only 50.0% of 
patients with MTS type 2 achieved seizure freedom, while 25.0% 
patients remain showing rare disabling seizures (Engel 2) and the 
other 25.0% had a worthwhile improvement (Table 4).
DiScUSSiON
Up to one-third of individuals with TLE still present sei-
zures after surgical treatment10,11. The identification of prog-
nostic factors in an attempt to better predict postoperative 
Mean age of 
epilepsy onset 
(SD) years
Mean age at 
surgery (SD) 
years
Mean duration 
of epilepsy 
(SD) years
No MTS 19.0 (6.56) 28.3 (10.60) 9.3 (4.62)
N=3 (4.5%)
MTS type 1a 13.0 (10.55) 38.0 (10.15) 25.6 (13.76)
N=18 (27.3%)
MTS type 1b 14.4 (9.23) 37.6 (12.10) 23.1 (12.85)
N=41 (62.1%)
MTS type 2 16.5 (14.39) 34.5 (10.75) 18.0 (11.17)
N=4 (6.1%)
p=0.632 p=0.514 p=0.171
Table 2. Clinical data in MTS patterns.
Statistical analysis carried out between MTS groups. MTS: mesial temporal 
sclerosis; N: number of patients; SD: standard deviation.
CA1 mean (SD) CA2 mean (SD) CA3 mean (SD) CA4 mean (SD)
Neuronal cell densities (neurons x 10-4/µm²)
No MTS 3.20 (0.682) 2.84 (0.472) 2.60 (0.956) 1.92 (0.262)
MTS type 1a 0.59 (0.223) 2.21 (0.196) 1.60 (0.683) 0.58 (0.288)
MTS type 1b 0.54 (0.249) 0.98 (0.602) 0.76 (0.413) 0.51 (0.346)
MTS type 2 0.43 (0.151) 2.17 (1.300) 2.44 (0.712) 2.11 (0.671)
Controls 2.87 (0.655) 3.33 (0.678) 3.24 (1.085) 2.11 (0.492)
Neuronal density expressed as proportion (x 100) of control values
No MTS 111.4% (23.8) 85.3% (14.2) 80.2% (29.5) 91.1% (12.5)
MTS type 1a 20.6% (7.8) 66.4% (5.9) 49.3% (21.1) 27.5% (13.7)
MTS type 1b 18.9% (8.7) 29.5% (18.1) 23.5% (12.7) 24.3% (16.4)
MTS type 2 15.0% (5.3) 65.3% (39.0) 75.3% (22.0) 100.2% (31.9)
Table 1. Pathology measurement data.
MTS: mesial temporal sclerosis; SD: standard deviation.
IPI (N) FS (N) Mean age at IPI (SD) years
Latency 
(SD) years
No MTS 0.0% - - -
MTS type 1a 44.4% (8) 50.0% (4) 1.8 (1.37) 12.0 (6.76)
MTS type 1b 63.4% (26) 38.5% (10) 1.8 (1.43) 11.6 (7.12)
MTS type 2 0.0% - - -
p=0.011 p=0.689 p=0.789 p=0.984
Table 3. Histopathological patterns of hippocampal sclerosis 
and history of preceding events.
MTS type 2 and patients without MTS experienced no IPI. Statistical 
analysis carried out between MTS groups. MTS: mesial temporal 
sclerosis; IPI: initial precipitating insult; FS: febrile seizure; N: number 
of patients.
Engel 1 (N) Engel 2 (N) Engel 3 (N) Engel 4 (N) Total (N)
No MTS 0.0% (0) 33.3% (1) 33.3% (1) 33.3% (1) 100% (3)
MTS type 1a 83.3% (15) 16.7% (3) 0.0% (0) 0.0% (0) 100% (18)
MTS type 1b 75.6% (31) 14.6% (6) 4.9% (2) 4.9% (2) 100% (41)
MTS type 2 50.0% (2) 25.0% (1) 25.0% (1) 0.0% (0) 100% (4)
Total 72.7% (48) 16.7% (11) 6.1% (4) 4.5% (3) 100% (66)
p=0.034
Table 4. Histopathological patterns of hippocampal sclerosis and postsurgical outcome.
Values expressed as percentage of total for the mesial temporal sclerosis (MTS) groups in surgical outcome proposed by Engel et al. (1993). No MTS group was associated 
with the poorest outcome. MTS types 1a and 1b presented best postsurgical seizure control, while MTS type 2 had only 50% seizure relief. N: number of patients.
Within the surgical patients, 34 (51.5%) reported a his-
tory of initial precipitating insult (IPI) of whom 14 (41.2%) 
experienced complex febrile seizures, 12 (35.3%) afebrile sei-
zures, five (14.7%) meningitis and three (8.8%) head trauma. 
Occurrence of an IPI was not reported among MTS type 2 
and cases with no HS (Table 3). The age of IPI and the latent 
period between the preceding event and the onset of habitual 
seizures was not significantly different.
Forty-eight patients (72.7%) became seizure-free after sur-
gery. The poorest outcome occurred in patients with normal hip-
pocampal cell densities (no MTS) with all of them still presenting 
seizures at the last follow-up visit after surgery (Table 4). Better 
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outcome is critical to select the best surgical candidates and 
to improve clinical management of epilepsy surgery.
The agreement records of the MRI, ictal and interictal EEG, 
neuropsychological tests and positron emission tomography 
pointing to a unilateral and localized epileptogenic zone have 
already been shown to favor surgical prognosis12-14.
Histopathological evaluation of the surgical specimens 
have also been suggested as a predictor of postoperative sei-
zure control6,7,15. A favorable outcome has been related to 
a greater degree of hippocampal atrophy neuropathologi-
cally diagnosed as classical HS7,13,16. Otherwise, the atypical 
patterns of hippocampal neuronal loss may predict poorer 
outcome7,15,17. The identification of distinct patterns of HS 
may suggest different clinical histories and epileptogenic 
pathways, and disassociate HS as a single condition.
In this study, we applied a quantitative analytical method 
to determine the patterns of HS, according to Blümcke’s clas-
sification7, in our surgical series. Despite electrophysiological 
evidence for TLE, three surgical specimens did not present 
specific neuronal cell loss. This finding has been reported in 
similar surveys1,6,7,15,18 and no long has been explained.
Despite our small cohort of patients, this is a pure series 
of TLE-MTS since individuals with a second potentially ep-
ileptogenic pathology (dual pathology) were excluded and 
all patients had been submitted to the same clinical case re-
cords and surgical procedure, excluding other influences on 
outcome. A possible disadvantage of our methodology is the 
fact that only a single section of hippocampus was analyzed. 
This section is thought to be representative of all hippocam-
pal pathology, but patterns of HS could vary along the antero-
posterior axis of hippocampus in some patients19, suggesting 
a possible pathological bias.
Our data are consistent with previous studies with regard 
to seizure frequency and age at surgery, suggesting no corre-
lation between them and the pattern of HS7,20,21. Also, duration 
of epilepsy in our series is suggested to be shorter for patients 
with normal hippocampus6,7. Mean age of epilepsy onset did 
not show an influence on the patterns of neuronal cell loss, 
unlike reported by Thom et al.6.
IPI, considered as a necessary event to generate the 
pattern of HS associated with chronic epilepsy, is a central 
nervous system insult occurring up to six years of age. The 
controversy over the importance of the age of IPI as a good 
outcome predictor has been reported6,7. In our series, no as-
sociation between age and type of IPI with severity of hip-
pocampal pathology was found. In this survey, patients with 
hippocampal neuronal cell loss restricted to CA1 sector 
(MTS type 2) did not report a history of IPI, which might be 
due to a small number of cases presenting this pathology.
In our cohort of TLE patients, 72.7% became seizure-free 
after surgery, which is consistent with the majority of surgi-
cal series in literature22-25. The best outcome was achieved by 
MTS type 1a and MTS type 1b groups, reproducing previous 
reports6,7. In this series, any patients without hippocampal 
neuronal cell loss (no MTS) have a benefit from epilepsy sur-
gery, contradicting earlier studies in which seizure-free out-
come ranged from 44–58%6,7,15. This can be justified by our 
small number of patients presenting MTS type 2 and normal 
hippocampal structure.
In conclusion, the analysis of hippocampal neuronal loss 
patterns immediately after surgery may be used as a predic-
tor of long-term seizure outcome.
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